Intraocular pressure reduction using a fixed combination of timolol maleate 0.5% and brimonidine tartrate 0.2% administered three times daily

BACKGROUND: The purpose of this study was to evaluate the safety and efficacy of a fixed combination of timolol maleate 0.5% + brimonidine tartrate 0.2% (Combigan®) for reduction for intraocular pressure (IOP) in patients with glaucoma when the dose frequency is increased from twice to three times d...

Descripción completa

Detalles Bibliográficos
Autores principales: Moisseiev, Elad, Kurtz, Shimon, Lazar, Moshe, Shemesh, Gabi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699296/
https://www.ncbi.nlm.nih.gov/pubmed/23836956
http://dx.doi.org/10.2147/OPTH.S47760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699296/
https://www.ncbi.nlm.nih.gov/pubmed/23836956
http://dx.doi.org/10.2147/OPTH.S47760

Ejemplares similares